P. Vlachoyiannopoulos

686 total citations
17 papers, 503 citations indexed

About

P. Vlachoyiannopoulos is a scholar working on Rheumatology, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, P. Vlachoyiannopoulos has authored 17 papers receiving a total of 503 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Rheumatology, 4 papers in Pathology and Forensic Medicine and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in P. Vlachoyiannopoulos's work include Systemic Lupus Erythematosus Research (10 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Platelet Disorders and Treatments (3 papers). P. Vlachoyiannopoulos is often cited by papers focused on Systemic Lupus Erythematosus Research (10 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Platelet Disorders and Treatments (3 papers). P. Vlachoyiannopoulos collaborates with scholars based in Greece, Australia and Italy. P. Vlachoyiannopoulos's co-authors include Athanasios G. Tzioufas, Peter J. Maddison, David Hough, R P Skinner, Marco Matucci‐Cerinic, C.P. Denton, Richard M. Silver, Salvatore D’Angelo, A. Siamopoulou‐Mavridou and G. Dimou and has published in prestigious journals such as Neurology, Annals of the Rheumatic Diseases and Journal of Autoimmunity.

In The Last Decade

P. Vlachoyiannopoulos

16 papers receiving 490 citations

Peers

Countries citing papers authored by P. Vlachoyiannopoulos

Since Specialization

Citations

This map shows the geographic impact of P. Vlachoyiannopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Vlachoyiannopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Vlachoyiannopoulos more than expected).

Fields of papers citing papers by P. Vlachoyiannopoulos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Vlachoyiannopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Vlachoyiannopoulos. The network helps show where P. Vlachoyiannopoulos may publish in the future.

Co-authorship network of co-authors of P. Vlachoyiannopoulos

This figure shows the co-authorship network connecting the top 25 collaborators of P. Vlachoyiannopoulos. A scholar is included among the top collaborators of P. Vlachoyiannopoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Vlachoyiannopoulos. P. Vlachoyiannopoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Interaction of HLA-DRB1 shared epitope and smoking on the development of anti-citrullinated protein antibody positive rheumatoid arthritis in Greek patients 2025 ·Clinical and Experimental Rheumatology ·(unknown), (unknown), Alexandra Tsirogianni, (unknown), (unknown), (unknown), Sοusana Gazi, P. Vlachoyiannopoulos	0
2	Clinical relevance of nitrated beta 2-glycoprotein I in antiphospholipid syndrome: Implications for thrombosis risk 2021 ·Journal of Autoimmunity ·(unknown), Miao Qi, Yiannis Ioannou, (unknown), Zohra Ahmadi, Jason W.H. Wong, P. Vlachoyiannopoulos, Haralampos Μ. Moutsopoulos, Takayoshi Koike, Allan Sturgess, Beng H. Chong, Steven A. Krilis, Bill Giannakopoulos	7
3	Differential CpG methylation of the promoter of interleukin 8 and the first intron of tissue factor in Antiphospholipid syndrome 2019 ·Journal of Autoimmunity ·(unknown), Panagiota Karagianni, (unknown), P. Vlachoyiannopoulos	15
4	Evidence of epigenetic alterations in thrombosis and coagulation: A systematic review 2019 ·Journal of Autoimmunity ·(unknown), P. Vlachoyiannopoulos	35
5	Osteoporosis and vascular calcification in postmenopausal women: a cross-sectional study 2016 ·Climacteric ·Christos Lampropoulos, (unknown), Maria Konsta, Ioanna Papaioannou, (unknown), (unknown), (unknown), P. Vlachoyiannopoulos	25
6	SAT0361 Large, Nation-Wide Data Analysis-Derived Estimated Prevalence of Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), and Systemic Sclerosis (SSC) in Caucasians: Insights from the Identification of Patients with Prescribed Pharmacological Treatment Among 7.742.629 Greek Citizens 2015 ·Annals of the Rheumatic Diseases ·P. Sfikakis, George Dafoulas, Dimitrios T. Boumpas, Alexandros A. Drosos, George D. Kitas, Stamatis‐Nick C. Liossis, (unknown), Prodromos Sidiropoulos, Lazaros I. Sakkas, Athanasios G. Tzioufas, Dimitrios Vassilopoulos, P. Vlachoyiannopoulos, (unknown), (unknown), (unknown)	1
7	Sjogren’s syndrome: An update on clinical, basic and diagnostic therapeutic aspects 2012 ·Journal of Autoimmunity ·Athanasios G. Tzioufas, P. Vlachoyiannopoulos	41
8	Incidence and Prevalence of Major Central Nervous System (CNS) Involvement in Systemic Lupus Erythematosus (SLE): A 3 Year Prospective Evaluation and Clinical Correlations in 456 Patients (S08.004) 2012 ·Neurology ·Eleni Kampylafka, Harry Alexopoulos, (unknown), P. Vlachoyiannopoulos, M. C. Dalakas, H M Moutsopoulos, Athanasios G. Tzioufas	9
9	Estrogen receptor alpha gene polymorphism and systemic lupus erythematosus: a possible risk? 2005 ·Lupus ·Eva Kassi, P. Vlachoyiannopoulos, A. Kominakis, Hippokratis Kiaris, Haralampos Μ. Moutsopoulos, Paraskevi Moutsatsou	16
10	Atherosclerosis in premenopausal women with antiphospholipid syndrome and systemic lupus erythematosus: a controlled study 2003 ·British journal of rheumatology ·P. Vlachoyiannopoulos	92
11	Assessment of lung involvement. 2003 ·PubMed ·Marco Matucci‐Cerinic, Salvatore D’Angelo, C.P. Denton, P. Vlachoyiannopoulos, Richard M. Silver	44
12	Systemic scleroderma in Greece: low mortality and strong linkage with HLA-DRB11104 allele 2000 ·Annals of the Rheumatic Diseases* ·P. Vlachoyiannopoulos, (unknown), (unknown), (unknown), (unknown), (unknown)	56
13	Antibodies to β2-Glycoprotein-I: Urea Resistance, Binding Specificity, and Association with Thrombosis 1998 ·Journal of Clinical Immunology ·P. Vlachoyiannopoulos, (unknown), (unknown), (unknown), (unknown)	37
14	Safety and efficacy of recombinant gamma interferon in the treatment of systemic sclerosis. 1996 ·Annals of the Rheumatic Diseases ·P. Vlachoyiannopoulos, Niki Tsifetaki, Ioanna Maria Dimitriou, Dimitrios Galaris, Spyridon Papiris, H M Moutsopoulos	27
15	Chorea as a manifestation of the antiphospholipid syndrome in childhood. 1991 ·PubMed ·P. Vlachoyiannopoulos, G. Dimou, A. Siamopoulou‐Mavridou	22
16	Circulating antibodies to prothymosin α in systemic lupus erythematosus 1989 ·Clinical Immunology and Immunopathology ·P. Vlachoyiannopoulos, Stathis Frillingos, Athanasios G. Tzioufas, K. Seferiadis, Haralampos Μ. Moutsopoulos, Orestes Tsolas	12
17	Antibodies to nRNP, Sm, Ro(SSA) and La(SSB) detected by ELISA: their specificity and inter-relations in connective tissue disease sera. 1985 ·PubMed ·Peter J. Maddison, R P Skinner, P. Vlachoyiannopoulos, (unknown), David Hough	64

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact